The pause of Johnson & Johnson’s trials poses another setback for global efforts to develop a shot to protect lives and jump-start economies battered by the pandemic, as well as a reminder of the challenges of fast-tracking vaccine development
it is developing with the University of Oxford, citing similar reasons. AstraZeneca has since resumed trials in the U.K., but a large U.S. study remains on hold.
The dual setbacks affect two of four front-runner vaccine candidates being developed in the West. With winter approaching, world leaders hoped late-stage clinical trials could translate into approved vaccines that could be distributed to those most in need, including health care workers, and eventually to the broader population.
The prospect of a Covid-19 vaccine by year’s end has been a feature of political campaigns in the U.S. and fueled hopes for the reopening of countries in Europe and elsewhere. That has been underscored recently by rising coronavirus infection rates that have led to new lockdowns and kept millions of workers and students at home.as the J&J news prompted concern that it could take longer than expected for a vaccine to be widely available.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Johnson & Johnson Halt All Covid-19 Vaccine Trials Over ‘Unexplained Illness’The pause includes late-stage stage trials for the group’s single dose Covid-19 vaccine.
Read more »
2nd COVID-19 vaccine trial paused over unexplained illnessA late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot
Read more »
Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'Johnson&Johnson said its Janssen arm had paused its coronavirus vaccine trial after an 'unexplained illness' in one of the volunteers testing its experimental Covid-19 shot.
Read more »
Second COVID-19 vaccine trial paused over unexplained illnessA late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.
Read more »
Johnson & Johnson pauses clinical trials for a Covid vaccine over patient illnessThe trial was paused after an “unexplained” illness in one of its participants and in compliance with regulatory standards, the company said.
Read more »
2nd COVID-19 vaccine trial paused over unexplained illnessBREAKING: Johnson & Johnson pauses its COVID-19 vaccine trial while the company investigates a participant’s “unexplained illness.” The company said such illnesses, accidents and similar adverse events are an expected part of large clinical studies.
Read more »